X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Abstract : ABSTRACT: X-linked adrenoleukodystrophy (X-ALD) is the most common peroxisomal disorder. The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal membrane protein ALDP which is involved in the transmembrane transport of very long-chain fatty acids (VLCFA; >C22). A defect in ALDP results in elevated levels of VLCFA in plasma and tissues. The clinical spectrum in males with X-ALD ranges from isolated adrenocortical insufficiency and slowly progressive myelopathy to devastating cerebral demyelination. The majority of heterozygous females will develop symptoms by the age of 60 years. In individual patients the disease course remains unpredictable. This review focuses on the diagnosis and management of patients with X-ALD and provides a guideline for clinicians that encounter patients with this highly complex disorder.
docType_s : Journal articles
Domain :


http://www.hal.inserm.fr/inserm-00755770
Contributor : BMC Ed. <>
Submitted on : Wednesday, November 21, 2012 - 9:00:10 PM
Last modification on : Wednesday, November 21, 2012 - 9:00:10 PM

Identifiers

Collections

Citation

Marc Engelen, Stephan Kemp, Marianne De Visser, Björn Van Geel, Ronald Wanders, et al.. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.. Orphanet Journal of Rare Diseases, BioMed Central, 2012, 7 (1), pp.51. <10.1186/1750-1172-7-51>. <inserm-00755770>

Export

Share

Metrics